QIAGEN Significantly Expands its Portfolio of Licenses to real-time PCR
Two New Licenses Added to Technology Portfolio targeting Molecular Diagnostics
16-Feb-2007 -
QIAGEN N.V. announced that it has acquired licenses from Roche, as well as from Ortho Clinical Diagnostics. According to the company, these two license agreements significantly expand QIAGEN's rights to real-time polymerase chain reaction (PCR) for use in In Vitro Diagnostics (IVD). Financial ...
diagnostic tests
diagnostics
license agreements
+6